Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study [西班牙社区居民SARS-CoV-2感染的死亡风险：全国血清流行病学研究]

• 分享：

BMJ 2020; 371 doi: https://doi.org/10.1136/bmj.m4509 (Published 27 November 2020)
Cite this as: BMJ 2020;371:m4509

Authors
Roberto Pastor-Barriuso, Beatriz Pérez-Gómez, Miguel A Hernán, Mayte Pérez-Olmeda, Raquel Yotti, Jesús Oteo-Iglesias, Jose L Sanmartín, Inmaculada León-Gómez, Aurora Fernández-García, Pablo Fernández-Navarro, Israel Cruz, Mariano Martín, Concepción Delgado-Sanz, Nerea Fernández de Larrea, Jose León Paniagua, Juan F Muñoz-Montalvo, Faustino Blanco, Amparo Larrauri, Marina Pollán

Abstract
Objective To estimate the infection fatality risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), based on deaths with confirmed coronavirus disease 2019 (covid-19) and excess deaths from all causes.

Design Nationwide seroepidemiological study.

Setting First wave of covid-19 pandemic in Spain.

Participants Community dwelling individuals of all ages.

Main outcome measures The main outcome measure was overall, and age and sex specific, infection fatality risk for SARS-CoV-2 (the number of covid-19 deaths and excess deaths divided by the estimated number of SARS-CoV-2 infections) in the community dwelling Spanish population. Deaths with laboratory confirmed covid-19 were obtained from the National Epidemiological Surveillance Network (RENAVE) and excess all cause deaths from the Monitoring Mortality System (MoMo), up to 15 July 2020. SARS-CoV-2 infections in Spain were derived from the estimated seroprevalence by a chemiluminescent microparticle immunoassay for IgG antibodies in 61 098 participants in the ENE-COVID nationwide seroepidemiological survey between 27 April and 22 June 2020.

Results The overall infection fatality risk was 0.8% (19 228 of 2.3 million infected individuals, 95% confidence interval 0.8% to 0.9%) for confirmed covid-19 deaths and 1.1% (24 778 of 2.3 million infected individuals, 1.0% to 1.2%) for excess deaths. The infection fatality risk was 1.1% (95% confidence interval 1.0% to 1.2%) to 1.4% (1.3% to 1.5%) in men and 0.6% (0.5% to 0.6%) to 0.8% (0.7% to 0.8%) in women. The infection fatality risk increased sharply after age 50, ranging from 11.6% (8.1% to 16.5%) to 16.4% (11.4% to 23.2%) in men aged 80 or more and from 4.6% (3.4% to 6.3%) to 6.5% (4.7% to 8.8%) in women aged 80 or more.

Conclusion The increase in SARS-CoV-2 infection fatality risk after age 50 appeared to be more noticeable in men than in women. Based on the results of this study, fatality from covid-19 was greater than that reported for other common respiratory diseases, such as seasonal influenza.